a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
Industry Biotechnology
A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.
Ticker / NAME | Correlation To FULC | 1D Price Change % | ||
---|---|---|---|---|
FULC | 100% | -2.20% | ||
ONCT - FULC | 54% Loosely correlated | -5.87% | ||
INZY - FULC | 51% Loosely correlated | -5.59% | ||
SCPH - FULC | 40% Loosely correlated | -0.51% | ||
ANNX - FULC | 40% Loosely correlated | -0.91% | ||
VRDN - FULC | 40% Loosely correlated | +0.22% | ||
More |